Ignite Creation Date:
2024-05-06 @ 3:27 PM
Last Modification Date:
2024-10-26 @ 1:49 PM
Study NCT ID:
NCT04634435
Status:
RECRUITING
Last Update Posted:
2023-08-29
First Post:
2020-10-21
Brief Title:
Autologous Memory-like NK Cell Therapy With BHV-1100 and Low Dose IL-2 in Multiple Myeloma Patients
Sponsor:
Biohaven Pharmaceuticals Inc
Organization:
Biohaven Pharmaceuticals Inc
Organization Data
Organization:
Biohaven Pharmaceuticals Inc
Class:
INDUSTRY
Study ID:
BHV1100-101 formerly KP001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Biohaven Pharmaceuticals Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Dana-Farber Cancer Institute | OTHER |